Latest Prescription Drugs news
Paxlovid Not Helpful for Reducing Most Post-COVID-19 Conditions
posted October 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
Biden Administration Urges Schools to Carry Naloxone
posted October 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
COVID-19 Meds Like Paxlovid Will Soon Have Big Price Tags
posted October 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Patisiran Can Preserve Functional Capacity in ATTR Amyloidosis
posted October 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
